Anterior Abdominal Blocks for Postoperative Pain Control in Obese Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to compare between two surgical techniques for anterior abdominal wall blocks in obese patients Undergoing Major Gynecological Surgery: Surgical Transversus Abdominis Plane \[TAP\] block versus Rectus Sheath block as regards the efficacy and adverse effects
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable postoperative-pain
Started Oct 2018
Typical duration for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 23, 2018
CompletedFirst Submitted
Initial submission to the registry
November 3, 2018
CompletedFirst Posted
Study publicly available on registry
November 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 23, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 23, 2020
CompletedAugust 23, 2021
August 1, 2021
1.3 years
November 3, 2018
August 19, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Total dose of morphine consumption
First 24 hours postoperatively
Secondary Outcomes (2)
Numerical rate scale
First 24 hours postoperatively
Postoperative respiratory functions
First 24 hours postoperatively
Study Arms (2)
Transversus Abdominis Block [TB] group
ACTIVE COMPARATORPatients will receive Surgical Transversus Abdominis Plane Block
Rectus Sheath Block [RB] group
ACTIVE COMPARATORPatients will receive Surgical Rectus Sheath Block
Interventions
At the end of operation and after hemostasis, 20 ml of 0.25% bupivacaine will be injected intra-abdominally into the Transversus Abdominis plane at the midpoint of the line connecting the crista iliaca and inferior costal margin and at two locations in the lateral abdominal wall at 3-4 cm inferior to the previous midline injection. The same procedure will be repeated on the opposite side using an identical amount of local anesthetic.
At the end of operation and after hemostasis,20 ml 0.25% bupivacaine will be administered slowly under direct vision after careful aspiration to the rectus sheath space which is present inbetween rectus abdominis muscle and the posterior layer of its sheath at the upper pole of the midline incision by time of closure of the anterior abdominal wall. The procedure will be repeated on the opposite side.
Eligibility Criteria
You may qualify if:
- female patients
- undergoing major gynecological surgery with supraumbilical midline incision the first time
- Body mass index (BMI) more than 40.
You may not qualify if:
- patient refusal to participate in the study,
- reoperation,
- addiction
- alcohol abuse
- hypersensitivity or allergy to the study drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University hospitals
Cairo, 11591, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marwa AK Elbeialy, MD
Faculty of Medicine,Ain Shams University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Anesthesia
Study Record Dates
First Submitted
November 3, 2018
First Posted
November 6, 2018
Study Start
October 23, 2018
Primary Completion
January 23, 2020
Study Completion
January 23, 2020
Last Updated
August 23, 2021
Record last verified: 2021-08